TCT (BVI) Limited - Net Worth and Insider Trading

TCT (BVI) Limited Net Worth

The estimated net worth of TCT (BVI) Limited is at least $91 Million dollars as of 2025-03-26. TCT (BVI) Limited is the of HighTide Therapeutics Inc and owns about 53,095,764 shares of HighTide Therapeutics Inc (HKSE:02511) stock worth over $91 Million. Details can be seen in TCT (BVI) Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that TCT (BVI) Limited has not made any transactions after 2023-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of TCT (BVI) Limited

TCT (BVI) Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, TCT (BVI) Limited owns 1 companies in total, including HighTide Therapeutics Inc (HKSE:02511) .

Click here to see the complete history of TCT (BVI) Limited’s form 4 insider trades.

Insider Ownership Summary of TCT (BVI) Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:02511	HighTide Therapeutics Inc	2023-12-22

TCT (BVI) Limited Latest Holdings Summary

TCT (BVI) Limited currently owns a total of 1 stock. TCT (BVI) Limited owns 53,095,764 shares of HighTide Therapeutics Inc (HKSE:02511) as of December 22, 2023, with a value of $91 Million.

Latest Holdings of TCT (BVI) Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:02511	HighTide Therapeutics Inc	2023-12-22	53,095,764	1.72	91,324,714

Holding Weightings of TCT (BVI) Limited

TCT (BVI) Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, TCT (BVI) Limited has made a total of 1 transactions in HighTide Therapeutics Inc (HKSE:02511) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in HighTide Therapeutics Inc is the sale of 0 shares on December 22, 2023, which brought TCT (BVI) Limited around $0.

Insider Trading History of TCT (BVI) Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

TCT (BVI) Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

TCT (BVI) Limited Ownership Network

Ownership Network List of TCT (BVI) Limited

No Data

Ownership Network Relation of TCT (BVI) Limited

TCT (BVI) Limited Owned Company Details

What does HighTide Therapeutics Inc do?

Who are the key executives at HighTide Therapeutics Inc?

TCT (BVI) Limited is the of HighTide Therapeutics Inc. Other key executives at HighTide Therapeutics Inc include 2101 Beneficial owner MA Lixiong , 2101 Beneficial owner LIU Liping , and 2202 Interest of your spouse Li Tan .

HighTide Therapeutics Inc (HKSE:02511) Insider Trades Summary

Over the past 18 months, TCT (BVI) Limited made 1 insider transaction in HighTide Therapeutics Inc (HKSE:02511) with a net sale of 0. Other recent insider transactions involving HighTide Therapeutics Inc (HKSE:02511) include a net sale of 38,135,000 shares made by Li Li , a net sale of 38,135,000 shares made by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. , and a net sale of 38,135,000 shares made by Li Tan .

In summary, during the past 3 months, insiders sold 0 shares of HighTide Therapeutics Inc (HKSE:02511) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,405,000 shares of HighTide Therapeutics Inc (HKSE:02511) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,405,000 shares.

HighTide Therapeutics Inc (HKSE:02511)'s detailed insider trading history can be found in Insider Trading Tracker table.

HighTide Therapeutics Inc Insider Transactions

No Available Data

TCT (BVI) Limited Mailing Address

Above is the net worth, insider trading, and ownership report for TCT (BVI) Limited. Currently GuruFocus does not have mailing address information for TCT (BVI) Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.